Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 6 Completed 3 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cyclophosphamide 89 Capecitabine 88 Trastuzumab 81 Docetaxel 81 Paclitaxel 65 Epirubicin 57 pyrotinib 55 Tamoxifen 54 Letrozole 53 Fulvestrant 49 Vinorelbine 43 Carboplatin 43 Doxorubicin 41 Radiotherapy 33 Anastrozole 32 exemestane 31 Neoadjuvant Therapy 29 palbociclib 27 Drug Therapy 27 Fluorouracil 24 Bevacizumab 24 pertuzumab 23 Cisplatin 23 eribulin 22 Exercise 21 130-nm albumin-bound paclitaxel 21 Goserelin 20 Gemcitabine 20 Chemotherapy, Adjuvant 19 Albumin-Bound Paclitaxel 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × patritumab deruxtecan × Breast × Clear all

NCT04610528 2023-06-23

TOT-HER3

SOLTI Breast Cancer Research Group

Phase EARLY_PHASE1 Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡